Maureen T Cronin

Title: Unveiling the Innovations of Maureen T Cronin: Pioneering Breast Cancer Diagnostics

Introduction:

Maureen T Cronin, a brilliant inventor hailing from Los Altos, CA, has made significant strides in the field of breast cancer diagnostics with a remarkable portfolio of 28 patents. Her groundbreaking work has revolutionized the way we approach the diagnosis and prognosis of this prevalent disease.

Latest Patents:

1. Gene expression markers for breast cancer prognosis: Cronin's invention provides crucial gene sets whose expression plays a vital role in diagnosing and predicting the outlook of patients with breast cancer.

2. Gene expression profiling in biopsied tumor tissues: This patent introduces precise methods for measuring mRNA levels in biopsied tumor tissues, particularly in archived paraffin-embedded biopsy material. It also encompasses the identification of important breast cancer gene sets for effective diagnosis and treatment strategies.

Career Highlights:

Throughout her career, Maureen T Cronin has contributed significantly to companies at the forefront of genetic research. Notably, she has lent her expertise to renowned organizations such as Genomic Health, Inc. and Affymetrix, Inc., where her innovative spirit has led to groundbreaking advancements in the field of oncology.

Collaborations:

Collaborating with accomplished professionals such as Joffre B Baker and Mark S Chee, Cronin has synergized her talents with like-minded visionaries to propel the boundaries of breast cancer research further. Together, they have paved the way for novel approaches to personalized medicine tailored to individual patients.

Conclusion:

In conclusion, Maureen T Cronin's dedication to advancing breast cancer diagnostics through innovative gene expression studies has cemented her legacy as a trailblazer in the field of oncology. Her patents serve as a testament to her unwavering commitment to improving patient outcomes and revolutionizing the landscape of modern medicine.